Sandoz Canada Joins Humira Biosimilar Race With Hyrimoz Approval
Enoxaparin Biosimilar Inclunox Also Approved By Health Canada
Sandoz Canada is looking to roll out its biosimilar to AbbVie’s Humira early in the new year following approval from Health Canada, with multiple other adalimumab candidates also reportedly approved.
